Related Experiment Video
Updated: Mar 22, 2026

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
Published on: March 17, 2023
Adipose tissue mTORC2 regulates ChREBP-driven de novo lipogenesis and hepatic glucose metabolism
Yuefeng Tang1, Martina Wallace2, Joan Sanchez-Gurmaches1
1Program in Molecular Medicine, University of Massachusetts Medical School, 373 Plantation Street, Worcester, Massachusetts 01605, USA.
Abstract:
Adipose tissue de novo lipogenesis (DNL) positively influences insulin sensitivity, is reduced in obesity, and predicts insulin resistance. Therefore, elucidating mechanisms controlling adipose tissue DNL could lead to therapies for type 2 diabetes. Here, we report that mechanistic target of rapamycin complex 2 (mTORC2) functions in white adipose tissue (WAT) to control expression of the lipogenic transcription factor ChREBPβ. Conditionally deleting the essential mTORC2 subunit Rictor in mature adipocytes decreases ChREBPβ expression, which reduces DNL in WAT, and impairs hepatic insulin sensitivity. Mechanistically, Rictor/mTORC2 promotes ChREBPβ expression in part by controlling glucose uptake, but without impairing pan-AKT signalling. High-fat diet also rapidly decreases adipose tissue ChREBPβ expression and insulin sensitivity in wild-type mice, and does not further exacerbate insulin resistance in adipose tissue Rictor knockout mice, implicating adipose tissue DNL as an early target in diet-induced insulin resistance. These data suggest mTORC2 functions in WAT as part of an extra-hepatic nutrient-sensing mechanism to control glucose homeostasis.
Insights
Mechanistic target of rapamycin complex 2 (mTORC2) in white adipose tissue controls glucose metabolism and insulin sensitivity by regulating de novo lipogenesis (DNL). This pathway is crucial for managing type 2 diabetes and obesity.
Area of Science:
- Metabolism and Endocrinology
- Cellular Signaling
- Molecular Biology
Background:
- Adipose tissue de novo lipogenesis (DNL) is vital for insulin sensitivity and impaired in obesity and insulin resistance.
- Understanding DNL regulation in adipose tissue is key for developing type 2 diabetes therapies.
Purpose of the Study:
- To investigate the role of mechanistic target of rapamycin complex 2 (mTORC2) in white adipose tissue (WAT) in regulating DNL and insulin sensitivity.
- To elucidate the molecular mechanisms by which mTORC2 influences lipogenesis and glucose homeostasis.
Main Methods:
- Conditional deletion of the mTORC2 subunit Rictor in mature adipocytes of mice.
- Analysis of ChREBPβ expression, DNL rates, glucose uptake, and insulin sensitivity in WAT and liver.
- Assessment of diet-induced insulin resistance models.
Main Results:
- Rictor deletion in WAT adipocytes reduced ChREBPβ expression, decreased WAT DNL, and impaired hepatic insulin sensitivity.
- mTORC2 signaling promotes ChREBPβ expression partly via glucose uptake, without affecting pan-AKT signaling.
- High-fat diet rapidly decreased adipose tissue ChREBPβ expression and insulin sensitivity, independent of Rictor deletion.
Conclusions:
- mTORC2 in WAT regulates ChREBPβ expression and DNL, impacting systemic insulin sensitivity.
- Adipose tissue DNL is an early target in diet-induced insulin resistance.
- mTORC2 in WAT acts as an extra-hepatic nutrient sensor controlling glucose homeostasis.
More Related Videos
07:34Quantitative Determination of De Novo Fatty Acid Synthesis in Brown Adipose Tissue Using Deuterium Oxide
Published on: May 12, 2023
06:08Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
Published on: May 19, 2023
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Lipid Catabolism
Cell Specific Gene Expression
cAMP-dependent Protein Kinase Pathways
Insulin: The Receptor and Signaling Pathways
Regulation of Metabolism